Accelerating access to paediatric medicines: lessons learned from the Global Accelerator for Paediatric Formulations, a WHO-hosted network

Despite advances in reducing neonatal and child mortality, children still face inequitable access to appropriately designed medicines, which endangers their health. Children need formulations that are dose appropriate, palatable, and easy to administer by caregivers, to reduce pill burden and ensure compliance. However, appropriate paediatric medicines are often non-existent, unavailable, costly, of inadequate quality, or have insufficient stability, especially in low-income and middle-income countries (LMICs).